Concepedia

Will Donnellan

WD

8

Publications

2K

Citations

8

H-Index

2012

Active since

Affiliations

Sarah Cannon(Current)

Cornell University

Northwestern University

Emory University

The University of Texas MD Anderson Cancer Center

Will Donnellan is an author at Sarah Cannon specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

2012–2022

8

Publications

8

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 363 citations · Full text

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

Justin M. Watts, Maria R. Baer, Jay Yang et al. · The Lancet Haematology · 2022 · 111 citations · Full text

, , +9

Examining racial differences in diffuse large B-cell lymphoma presentation and survival

Christopher R. Flowers, Pareen J. Shenoy, Uma Borate et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 55 citations · Full text

, , +24

Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study

Courtney D. DiNardo, Stéphane de Botton, Eytan M. Stein et al. · Blood · 2017 · 22 citations

Rows per page

1–5 of 8